NO20043441L - Orodispersibel farmasoytisk sammensetning omfattende agomelatin - Google Patents

Orodispersibel farmasoytisk sammensetning omfattende agomelatin

Info

Publication number
NO20043441L
NO20043441L NO20043441A NO20043441A NO20043441L NO 20043441 L NO20043441 L NO 20043441L NO 20043441 A NO20043441 A NO 20043441A NO 20043441 A NO20043441 A NO 20043441A NO 20043441 L NO20043441 L NO 20043441L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
agomelatine
orodispersible pharmaceutical
orodispersible
agomelatin
Prior art date
Application number
NO20043441A
Other languages
English (en)
Other versions
NO333712B1 (no
Inventor
Herve Rolland
Patrick Wuthrich
Marc Julien
Francois Tharrault
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20043441L publication Critical patent/NO20043441L/no
Publication of NO333712B1 publication Critical patent/NO333712B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører en fast orodispersibel farmasøytisk sammensetning av agomelatin,ved at den omfatter agomelatin og granuler bestående av kotørket laktose og stivelse.
NO20043441A 2002-01-23 2004-08-18 Orodispersibel farmasoytisk sammensetning omfattende agomelatin NO333712B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200792A FR2834890B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible d'agomelatine
PCT/FR2003/000197 WO2003061644A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible d’agomelatine

Publications (2)

Publication Number Publication Date
NO20043441L true NO20043441L (no) 2004-08-18
NO333712B1 NO333712B1 (no) 2013-09-02

Family

ID=27589556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043441A NO333712B1 (no) 2002-01-23 2004-08-18 Orodispersibel farmasoytisk sammensetning omfattende agomelatin

Country Status (27)

Country Link
US (2) US20050131071A1 (no)
EP (1) EP1467724B1 (no)
JP (2) JP4335011B2 (no)
KR (1) KR100605798B1 (no)
CN (1) CN1287780C (no)
AR (1) AR038207A1 (no)
AT (1) ATE324882T1 (no)
AU (1) AU2003220786B2 (no)
BR (1) BRPI0307072B1 (no)
CA (1) CA2473201C (no)
CY (1) CY1105415T1 (no)
DE (1) DE60304993T2 (no)
DK (1) DK1467724T3 (no)
EA (1) EA007299B1 (no)
ES (1) ES2262999T3 (no)
FR (1) FR2834890B1 (no)
GE (1) GEP20063818B (no)
MA (1) MA27101A1 (no)
MX (1) MXPA04007198A (no)
NO (1) NO333712B1 (no)
NZ (1) NZ533843A (no)
PL (1) PL204937B1 (no)
PT (1) PT1467724E (no)
SI (1) SI1467724T1 (no)
UA (1) UA77752C2 (no)
WO (1) WO2003061644A1 (no)
ZA (1) ZA200405153B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
FR2890564B1 (fr) * 2005-09-09 2007-10-19 Servier Lab Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent
FR2890562B1 (fr) * 2005-09-09 2012-10-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime
FR2894475B1 (fr) * 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
BRPI0708556A2 (pt) * 2006-03-06 2011-05-31 Teva Pharma composição de ezetimiba
CN101206200B (zh) * 2006-12-19 2011-12-28 北京德众万全药物技术开发有限公司 一种分离分析阿戈美拉汀中间体及其终产品的hplc方法
WO2008137461A1 (en) * 2007-05-01 2008-11-13 Concert Pharmaceuticals Inc. Naphthyl(ethyl) acetamides
EP2359813A1 (en) * 2010-02-04 2011-08-24 Ratiopharm GmbH Pharmaceutical composition comprising N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamid
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN102579415B (zh) * 2011-01-14 2014-11-05 成都康弘药业集团股份有限公司 一种含有阿戈美拉汀的口腔粘膜或舌下给药的药物组合物
EP2665465A1 (en) 2011-01-17 2013-11-27 Takeda Pharmaceutical Company Limited Orally dispersible tablet
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
WO2012130837A1 (en) * 2011-03-28 2012-10-04 Ratiopharm Gmbh Solid agomelatine in non-crystalline form
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2562151A1 (en) * 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Processes for the preparation of agomelatine and its intermediates
JP6061924B2 (ja) 2011-10-14 2017-01-18 武田薬品工業株式会社 口腔内分散性製剤
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
CA2877410A1 (en) 2012-07-16 2014-01-23 Ratiopharm Gmbh Complex of agomelatine and cyclodextrin
CN102988315B (zh) * 2012-09-28 2017-11-17 浙江华海药业股份有限公司 阿戈美拉汀固体制剂的制备方法
FR3001894A1 (fr) * 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
PL2810656T3 (pl) 2013-06-06 2018-01-31 Zentiva Ks Preparaty agomelatyny zawierające agomelatynę w postaci kokryształów
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
CN103816129B (zh) * 2014-02-27 2020-04-28 浙江华海药业股份有限公司 阿戈美拉汀口崩片
CN104586797A (zh) * 2015-01-05 2015-05-06 万特制药(海南)有限公司 阿戈美拉汀分散片及其制备方法
CN106333929A (zh) * 2016-09-24 2017-01-18 万特制药(海南)有限公司 一种含有阿戈美拉汀的分散片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
NZ278678A (en) * 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
US6183775B1 (en) * 1996-05-13 2001-02-06 Novartis Consumer Health S.A. Buccal delivery system
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
DE69901938T3 (de) * 1998-03-06 2012-08-02 Aptalis Pharma S.R.L. Schnell zerfallende tablette
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
PL204937B1 (pl) 2010-02-26
UA77752C2 (uk) 2007-01-15
ATE324882T1 (de) 2006-06-15
EA007299B1 (ru) 2006-08-25
HK1076742A1 (en) 2006-01-27
NO333712B1 (no) 2013-09-02
US20050131071A1 (en) 2005-06-16
NZ533843A (en) 2005-08-26
BRPI0307072B1 (pt) 2017-05-02
FR2834890A1 (fr) 2003-07-25
CN1287780C (zh) 2006-12-06
CA2473201A1 (fr) 2003-07-31
JP2009137994A (ja) 2009-06-25
BR0307072A (pt) 2004-12-28
KR100605798B1 (ko) 2006-08-01
ES2262999T3 (es) 2006-12-01
AU2003220786B2 (en) 2007-08-02
JP2005523253A (ja) 2005-08-04
WO2003061644A1 (fr) 2003-07-31
CN1622804A (zh) 2005-06-01
GEP20063818B (en) 2006-05-10
MA27101A1 (fr) 2004-12-20
US20100260840A1 (en) 2010-10-14
EP1467724A1 (fr) 2004-10-20
KR20040075102A (ko) 2004-08-26
CA2473201C (fr) 2010-08-17
EA200400928A1 (ru) 2004-12-30
CY1105415T1 (el) 2010-04-28
JP4335011B2 (ja) 2009-09-30
ZA200405153B (en) 2005-08-31
MXPA04007198A (es) 2004-10-29
PL370160A1 (en) 2005-05-16
AR038207A1 (es) 2005-01-05
FR2834890B1 (fr) 2004-02-27
SI1467724T1 (sl) 2006-08-31
EP1467724B1 (fr) 2006-05-03
DE60304993T2 (de) 2007-01-18
DE60304993D1 (de) 2006-06-08
DK1467724T3 (da) 2006-08-28
PT1467724E (pt) 2006-08-31

Similar Documents

Publication Publication Date Title
EA200400928A1 (ru) Диспергируемая во рту фармацевтическая композиция агомелатина
WO2005041924A3 (en) Administration of levodopa and carbidopa
DK1490062T3 (da) Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf
NO20033165L (no) (+)-1-(3,4-diklorfenyl)-3-azabicyklo[3.1.0]heksan, sammensetning og anvendelse derav
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
AU2003220786A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
ATE330017T1 (de) Kallikrein gen
IS6378A (is) Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
IS7815A (is) 3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
EA200400927A1 (ru) Диспергируемая во рту фармацевтическая композиция ивабрадина
AU2002361337A8 (en) Amphoteric polysaccharide, composition and use
EA200400884A1 (ru) Диспергируемая во рту фармацевтическая композиция периндоприла
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
MY138799A (en) Orodispersible pharmaceutical composition of an antithrombotic compound
GB2409796B (en) Composition comprising proteinaceous material, its preparation and use
WO2004014938A3 (en) Thrombopoiesis-stimulating proteins having reduced immunogenicity
GEP20063819B (en) Orodispersible pharmaceutical composition comprising piribedil
AU2003283508A8 (en) .pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof
FR2847472B1 (fr) Nouvelles compositions pharmaceutiques notamment pour la prevention des pathologies cardio-vasculaires
DK1313489T3 (da) Farmaceutiske sammensætninger til behandling af mucositis, stomatitis og Behcet's syndrom
NO20033636L (no) Levothyroxin sammensetninger og fremgangsmåter
ITRM20020046A1 (it) Idroaeratore ad espansione e compressione.
ITMI20022460A1 (it) Prodotto alimentare e procedimento per la realizzazione dello stesso.
SI1467750T1 (sl) Farmacevtski sestavek perindoprila disperzen v ustih (orodisperzen)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees